Key messages from scientific research that's ready to be acted on
Got It, Hide thisChou R, Dana T, Bougatsos C, et al. Screening for Impaired Visual Acuity in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2016;315:915-33.
In older people with no eye symptoms or complaints, what are the benefits and harms of vision screening? What are the benefits and harms of treating early vision impairment?
Reduced clarity or sharpness of vision can decrease functioning and quality of life and increase risk of falls and other accidents. Although impaired vision is more common in older people, it may occur slowly and is not always identified or treated. Screening people who do not have eye complaints may or may not be of benefit.
The researchers did a systematic review based on studies available up to February 2015.
Key features of the trials were:
Screening
Treatment of vision impairment
Treatment is effective for several types of vision complaints in older people with no eye symptoms, but there is not enough evidence to assess the balance of benefits and harms of screening.
Questions | Conditions | Findings |
Screening | No known vision impairment (with or without corrective lenses) | 1 study of 3346 people found that universal screening identified impaired vision in 27% of people compared with 3% in targeted screening; however, groups did not differ for vision after 5 years. 3 studies of 4728 people found that screening did not differ from no screening, usual care, or delayed screening for vision or other clinical outcomes at up to 5 years. No studies assessed or reported harms of screening. |
Treatment | Refractive error (near-sightedness, far-sightedness, astigmatism) | 2 studies found that corrective lenses improved vision-related quality of life but not functional outcomes. 1 study of 156 people found that multifocal lenses were associated with increased risk of falls compared with unifocal lenses. |
| Cataracts | 1 study found that immediate cataract surgery for the first eye reduced risk of second falls compared with delayed surgery. |
| Dry age-related macular degeneration | 1 study of 2556 people found that antioxidant supplements reduced vision loss after 10 years. 1 study of 3476 people found that zinc reduced risk of death. 1 study of 300 people found that fish oil capsules reduced risk of developing cataracts, worsening cataracts, or need for cataract surgery but not vision loss. |
| Wet age-related macular degeneration | 4 studies found that vascular endothelial growth-factor inhibitors increased likelihood of improved vision compared with sham injections. 1 study found that ranibizumab did not reduce death after 2 years. |
| Age-related macular degeneration (wet or dry) | 1 study found that zinc was associated with hospitalization for genitourinary problems, and antioxidants were associated with increased risk of yellow skin. Antioxidant vitamins and minerals were not linked to adverse events. 1 study found that supplements did not differ from placebo for adverse events, serious adverse events, or serious adverse events involving the eye. |